MORGAN STANLEY PLC/CALL/DAVITA/140/0.1/20.12.24 | Real-time Bid/Ask 05:30:01 2024-05-20 EDT | ||
| 1.52 EUR / 1.59 EUR | +2.30% |
|
| Current month | -7.32% | ||
| 1 month | +40.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
DAVITA INC.
Latest news about DAVITA INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 1.52 | +11.76% |
| 24-05-16 | 1.36 | -4.23% |
| 24-05-15 | 1.42 | +3.65% |
| 24-05-14 | 1.37 | -2.14% |
| 24-05-13 | 1.4 | -1.41% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 02:13 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | DAVITA INC. |
| Issuer | Morgan Stanley |
| WKN | ME9GNS |
| ISIN | DE000ME9GNS2 |
| Date issued | 2024-03-01 |
| Strike | 140 $ |
| Maturity | 2024-12-20 (215 Days) |
| Parity | 10 : 1 |
| Emission price | 1.33 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.91 € |
|---|---|
| Lowest since issue | 0.99 € |
| Spread | 0.07 € |
| Spread % | 4.40% |
Company Profile
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows:
- supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad;
- other (4.7%).
Sector
-
Consensus: DaVita Inc.
Sell
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
139.8
USD
Average target price
142.2
USD
Spread / Average Target
+1.69%
- Stock Market
- Warrants
- Warrant
